首页> 外文期刊>Journal of Microencapsulation: Microcapsules Liposomes Nanoparticles Microcells Microspheres >Formulation of maltodextrin entrapped in polycaprolactone microparticles for protein and vaccine delivery: Effect of size determining formulation process variables of microparticles on the hydrodynamic diameter of BSA
【24h】

Formulation of maltodextrin entrapped in polycaprolactone microparticles for protein and vaccine delivery: Effect of size determining formulation process variables of microparticles on the hydrodynamic diameter of BSA

机译:聚己内酯微粒中用于蛋白质和疫苗递送的麦芽糖糊精的配方:微粒大小决定配方过程变量对BSA流体动力学直径的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Size of the microparticle and integrity of the released protein are two crucial factors which dictate the success of any protein or vaccine delivery system. The primary objective was to optimize bovine serum albumin (BSA) loaded polycaprolactone/maltodextrin (PCL/MD) microparticles in terms of its size and the hydrodynamic diameter of the released protein. The effect of size determining formulation process variables (SDFPV) of microparticles on the hydrodynamic diameter of protein antigen was determined. The SDFPV were optimized by a compromise between the microparticle size and the relative hydrodynamic stability of protein released from it. Percentage of secondary structure of the protein released from the optimized formulation as determined by circular dichroism spectra along with SELCON software was also similar to that of native BSA suggesting the potential of PCL/MD microparticles for protein or vaccine delivery.
机译:微粒的大小和释放的蛋白质的完整性是决定任何蛋白质或疫苗输送系统成功与否的两个关键因素。主要目的是优化牛血清白蛋白(BSA)负载的聚己内酯/麦芽糊精(PCL / MD)微粒的大小和释放蛋白的流体动力学直径。确定了微粒的大小确定制剂工艺变量(SDFPV)对蛋白质抗原的流体动力学直径的影响。 SDFPV通过在微粒大小和从中释放的蛋白质的相对流体动力学稳定性之间的折衷来优化。通过圆二色光谱以及SELCON软件确定的从优化配方中释放出的蛋白质二级结构百分比也与天然BSA相似,表明PCL / MD微粒具有潜在的蛋白质或疫苗递送能力。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号